Benralizumab subcutaneous (SC) vs placebo
Rate of exacerbations requiring emergency department treatment or admission · people with asthma
Benralizumab subcutaneous (SC) probably leads to lower rate of exacerbations requiring emergency department treatment or… compared with placebo (moderate certainty).
1 finding from 1 review
- Rate ratio 0.68 [0.47, 0.98]2 studies · 1537 participantsModerate